Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Cancer and Leukemia Group B National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00115505 |
RATIONALE: Studying quality-of-life, employment, peripheral neuropathy, and informal care costs in patients having cancer treatment may help identify the intermediate- and long-term effects of treatment on patients with breast cancer.
PURPOSE: This clinical trial is studying quality of life, employment, peripheral neuropathy, and informal care costs in women who are receiving chemotherapy for breast cancer.
Condition | Intervention |
---|---|
Breast Cancer Cancer-Related Problem/Condition |
Procedure: quality-of-life assessment |
Study Type: | Observational |
Official Title: | Quality of Life, Employment and Informal Care Cost Analysis in Women Receiving Adjuvant Chemotherapy for Breast Cancer With 0-3 Positive Axillary Lymph Nodes |
Estimated Enrollment: | 280 |
Study Start Date: | October 2005 |
Estimated Primary Completion Date: | October 2006 (Final data collection date for primary outcome measure) |
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter, companion study.
Patients complete quality of life, employment, and informal care cost questionnaires, and peripheral neuropathy assessments at baseline (before beginning treatment on protocol CALGB-40101), in weeks 5-6 and 9-10, and in months 9 and 18.
PROJECTED ACCRUAL: A total of 280 patients will be accrued for this study within 1 year.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Hormone receptor status:
PATIENT CHARACTERISTICS:
Age
Sex:
Menopausal status:
Performance status
Life expectancy
Hematopoietic:
Hepatic
Renal
Other:
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy:
Endocrine therapy:
Radiotherapy
Surgery
Study Chair: | Craig A. Bunnell, MD | Dana-Farber Cancer Institute |
Investigator: | Bruce E. Hillner, MD | Massey Cancer Center |
Investigator: | Jeanne Mandelblatt, MD, MPH | Lombardi Cancer Research Center |
Study ID Numbers: | CDR0000433266, CALGB-70301 |
Study First Received: | June 22, 2005 |
Last Updated: | January 15, 2009 |
ClinicalTrials.gov Identifier: | NCT00115505 |
Health Authority: | Unspecified |
quality of life stage I breast cancer stage II breast cancer |
Skin Diseases Quality of Life Breast Neoplasms Breast Diseases |
Neoplasms Neoplasms by Site |